Abl Biosciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 2.25 Cr
as on 17-07-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.63 Cr
as on 17-07-2024
- Satisfied Charges ₹ 5.50 Cr
as on 17-07-2024
- Revenue -15.52%
(FY 2023)
- Profit -48.25%
(FY 2023)
- Ebitda -29.45%
(FY 2023)
- Net Worth 12.57%
(FY 2023)
- Total Assets -8.16%
(FY 2023)
About Abl Biosciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.25 Cr.
The company currently has active open charges totaling ₹11.63 Cr. The company has closed loans amounting to ₹5.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Veeraiah Edara and Venkata Edara serve as directors at the Company.
- CIN/LLPIN
U01403TG2012PTC082635
- Company No.
082635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Abl Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veeraiah Edara  | Director | 23-Aug-2012 | Current |
| Venkata Edara | Director | 23-Aug-2012 | Current |
Financial Performance of Abl Biosciences.
Abl Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.52% decrease. The company also saw a substantial fall in profitability, with a 48.25% decrease in profit. The company's net worth Soared by an impressive increase of 12.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abl Biosciences?
In 2023, Abl Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Feb 2024 | ₹5.00 Cr | Open |
Others Creation Date: 08 Dec 2021 | ₹1.03 Cr | Open |
Others Creation Date: 22 Jun 2020 | ₹5.34 M | Open |
How Many Employees Work at Abl Biosciences?
Abl Biosciences has a workforce of 15 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abl Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abl Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
